Butterfly Network

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Butterfly Network reports Q4 growth, seeks CEO for tech scaling

Butterfly Network's Q4 2022 performance showed revenue growth and improved cost management.
The company's strengths lie in democratizing healthcare, international expansion, and cost efficiency.
Challenges include external factors affecting deployments and the ongoing CEO search.
Opportunities for growth include revenue expectations, product developments, and efficiency enhancements.

Butterfly Network reports stable Q1 revenue, eyes AI and home markets

Butterfly Network's Q1 2023 performance showed mixed results with flat revenue but improved margins and reduced EBITDA loss.
The company's strengths in democratizing medical imaging, AI utilization, and strong cash position position it well for future growth.
Challenges include product revenue decline, slower customer growth, and the need to address international distribution weaknesses.
Opportunities in AI, software expansion, home market penetration, and exciting developments offer avenues for future success.

Butterfly Network reports Q2 revenue, focuses on innovation and growth

Butterfly Network's Q2 2023 performance showed mixed results with growth in U.S. sales but a decline in international sales.
The company is leveraging core strengths, launching innovative products, and focusing on revenue growth initiatives.
Challenges include declining international sales and potential impact on current sales due to the upcoming iQ3 launch.
Opportunities lie in new product launches, e-commerce strategy, market expansion, and technology advancements beyond iQ3.

Butterfly Network reports Q3 revenue decline but eyes future growth

Butterfly Network's Q3 2023 performance reflects a strategic shift towards higher-margin offerings and improved operational efficiency.
The company's strengths in revolutionizing ultrasound imaging, education offerings, and partnerships position it for future growth.
Challenges include revenue decline, competitive landscape, and the need for sustained investment in R&D and operational improvements.
Opportunities in upcoming product launches, market expansion, and revenue-sharing agreements present avenues for growth and innovation.

Butterfly Network reports improved Q4 financials and plans expansion

Butterfly Network's financials improved in Q4 2023 with revenue decline but better margins.
Strategic focus on product innovation, global expansion, and revenue growth drivers.
Challenges include revenue decline, EBITDA loss, and potential regulatory impacts.
Opportunities lie in planned growth strategies, resource additions, and lobbying efforts.

Butterfly Network excels in Q1 2024, eyes global expansion

Butterfly Network's Q1 2024 showcased strong revenue growth and operational improvements.
While facing challenges with compliance and financial losses, the company is optimistic about growth.
Strategic priorities and innovative technologies position Butterfly for future success and market expansion.

Butterfly Network reports robust Q2 growth, eyes AI opportunities

Butterfly Network's Q2 performance reflects strong revenue growth, improved cost efficiency, and a positive outlook for the year. The company's strengths in sustainable revenue growth, AI advancements, and strategic partnerships enhance its competitive position. Challenges in regulatory compliance and market expansion require careful navigation, while opportunities in AI, partnerships, and clinical applications offer avenues for growth.

Butterfly Network posts robust Q3 results, eyes tech innovation for growth

Butterfly Network's Q3 2024 performance reflects strong revenue growth, improved profitability, and strategic initiatives for future expansion and innovation.
While facing challenges in managing EBITDA losses and regulatory compliance, the company's financial strength and growth outlook present a positive trajectory.
Opportunities in technological innovation, market expansion, and healthcare initiatives position Butterfly Network for sustained growth and competitive advantage in the industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Atlanta, Georgia--(Newsfile Corp. - February 17, 2022) -  Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Butterfly Network, Inc. ("Butterfly" or the "Company") (NYSE: BFLY) f/k/a Longview Acquisition Corp. The lawsuit alleges, among other things, that Butterfly made false and/or misleading statements regarding the Company's business, operations, and compliance policies.If you bought shares of Butterfly between February 16, 2021 and November 15, 2021, both dates inclusive, or were...

SHAREHOLDER ALERT: Holzer & Holzer Encourages Butterfly Network, Inc. (BFLY) f/k/a Longview Acquisition Corp. Investors With Significant Losses to Contact the Firm

San Diego, California--(Newsfile Corp. - February 16, 2022) - Shareholder Rights Law Firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Butterfly Network, Inc. ("Butterfly" or the "Company") f/k/a Longview Acquisition Corp. ("Longview") (NYSE: BFLY) who purchased Butterfly common stock between February 16, 2021 and November 15, 2021, both dates inclusive (the "Class Period"). To serve as lead plaintiff in this class action, you must move...

(BFLY) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Butterfly Network, Inc. f/k/a Longview Acquisition Corp. Class Action Lawsuit

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)---- $BFLY #earnings--Butterfly Network, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

Butterfly Network, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

GUILFORD, Conn.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, and Ambra Health, an Intelerad Company, and maker of a leading cloud-based, medical image management suite, today announced a partnership to accelerate and simplify interoperability for bedside imaging data. This partnership strengthens the scalability of Butterfly Blueprint™, Butterfly's enterprise platform, and will enhance access to, and sha

Butterfly Network Announces Partnership With Ambra Health to Enhance Ultrasound Data Integration

Butterfly Network is a broken SPAC with a lack of analyst coverage. The 2 analysts covering the stock predict over 80% upside in the stock.

Butterfly Network: Lack Of Coverage Offers Opportunity

Butterfly Network is a small-cap ($1.15B) portable, hand-held digital imaging device, and software young company.

Language Of The Butterfly Network

The stock price of Butterfly Network Inc (NYSE: BFLY) increased by 19.46% today. This is why it happened.

Butterfly Network Stock (BFLY): Why The Price Surged Today

The company announced preliminary fourth-quarter results this morning.

Why Butterfly Network Stock Is Soaring 20% Today

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)---- $BFLY--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the “Company”), a digital health company transforming care with next generation, point-of-care ultrasound (“POCUS”), today announced certain preliminary, unaudited results for the quarter and full year ended December 31, 2021. “Our team has performed well during the fourth quarter, with revenue exceeding our expectations,” said Dr. Todd Fruchterman, President and CEO of Butterfly. “Having announced

Butterfly Network, Inc. Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021

GUILFORD, Conn. & ROCHESTER, N.Y.--(BUSINESS WIRE)-- #JPM22--University of Rochester Medical Center to Deploy Butterfly Across Enterprise

University of Rochester Medical Center to Deploy Butterfly Across Enterprise

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), today announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference to be held virtually on January 10-13, 2022. Dr. Todd Fruchterman, President and CEO will present virtually on Tuesday, January 11, 2022, at 2:15 pm Eastern Time. A live webcast of the presentation and an archived recording will be available in the Events & Presentations section of the Butterfly Network

Butterfly Network to Present at the 40th Annual J.P. Morgan Healthcare Conference

Cadence Design Systems' (CDNS) Clarity 3D Solver offering is being utilized by Butterfly Network to improve the design of its ultrasound system.

Cadence (CDNS) Clarity 3D Solver Adopted by Butterfly Network

Butterfly Network, Inc. (BFLY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

What Makes Butterfly Network, Inc. (BFLY) a New Buy Stock

The company bounced back a day after its shares dropped more than 10%

Why Butterfly Network Stock Rose More Than 14% on Tuesday

The stock price of Butterfly Network Inc (NYSE: BFLY) increased by over 15% during intraday trading today. This is why it happened.

Butterfly Network (BFLY) Stock: Why The Price Surged Today

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought about 825,000 shares of Butterfly Network Inc.

Cathie Wood's ARK Invest Buys Nearly 825,000 Shares of Butterfly Network

On Monday, Butterfly Network Inc. (NYSE:BFLY) shares declined by more than 15% after announcing its most recent quarterly results. The company reported its fiscal third-quarter results before markets opened, beating analyst expectations on earnings.

Should you buy or sell Butterfly Network shares after smashing earnings estimates?

The digital health company reported disappointing earnings results and lowered full-year guidance.

Why Butterfly Network Was Down 20% on Monday

Butterfly Network, Inc. (BFLY) CEO Todd Fruchterman on Q3 2021 Results - Earning Call Transcript

We have had several rapid-return trades executed on this stock. Earnings showed a big sales miss but some good news on losses narrowing.

Butterfly Network: Investor Pain Is A Trader's Gain

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Butterfly Network Reports Third Quarter 2021 Financial Results

Butterfly Network Reports Third Quarter 2021 Financial Results

GUILFORD, Conn. & NEW YORK & DUBAI, UAE--(BUSINESS WIRE)--Abdul Latif Jameel Health and Butterfly Network to bring Butterfly iQ+ to the Middle East, North Africa, Turkey and India.

Abdul Latif Jameel Health and Butterfly Network enter strategic distribution partnership to bring Butterfly iQ+ ultrasound device to a potential 2 billion1 people across the Middle East, North Africa, Turkey & India

BRISBANE, Calif., OXFORD, England and GUILFORD, Conn.

Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), an innovative digital health company that is working to democratize medical imaging and improve global health equity, announced that it will report third quarter 2021 financial results and provide a business update on November 15, 2021, before the market opens. Dr. Todd Fruchterman, President and Chief Executive Officer, and Stephanie Fielding, Chief Financial Officer, will host a conference call an

Butterfly Network, Inc. to Report Third Quarter 2021 Financial Results on November 15, 2021

Quantum-Si

GUILFORD, Conn.--(BUSINESS WIRE)-- #Covid19--Detect™, Inc., a Connecticut-based health technology company, announced today that the National Institutes of Health (NIH) has selected the Detect™ Covid-19 Test to receive funding from the highly competitive Rapid Acceleration of Diagnostics Initiative (RADxSM). The $8.1 million contract will facilitate the development and scale up manufacturing of Detect's PCR-quality rapid at-home Covid-19 test to meet national testing demand. The Detect Covid-19 Test, curre

News for Butterfly Network Stock (BFLY)